Search

Hikma Pharmaceuticals PLC

Abierto

SectorSanidad

1,898 -1.35

Resumen

Variación precio

24h

Actual

Mínimo

1877

Máximo

1928

Métricas clave

By Trading Economics

Ingresos

-93M

133M

Ventas

-11M

1.6B

P/B

Media del Sector

15.451

57.333

BPA

1.27

Rentabilidad por dividendo

3.24

Margen de beneficios

8.537

Empleados

9,500

EBITDA

-211M

288M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+27.23% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.24%

2.63%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-930M

4.2B

Apertura anterior

1899.35

Cierre anterior

1898

Hikma Pharmaceuticals PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 abr 2025, 08:20 UTC

Charlas de Mercado

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Hikma Pharmaceuticals PLC previsión

Precio Objetivo

By TipRanks

27.23% repunte

Estimación a 12 Meses

Media 2,422.5 GBX  27.23%

Máximo 2,650 GBX

Mínimo 2,000 GBX

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Hikma Pharmaceuticals PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

5

Comprar

2

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.